Schedule 13D ownership disclosure
TransBiotec, Inc.
Security class unavailable · CUSIP: 89355G108
Event date: 2019-08-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001477932-19-005387
- Form type
- SC 13D
- Filer
- Bennington Charles Warren
- CIK
- CIK 1529973
- Filed
- Sep 13, 2019
- Reporting period
- Aug 28, 2019
- Description
- Schedule 13D beneficial ownership